Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC

Clinical trial NCT06694350 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06694350
Sponsor: Zhejiang Provincial People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2024-12-01
Primary completion: 2027-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.